• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941848350
Device Problems Break (1069); Deflation Problem (1149); Difficult to Remove (1528)
Patient Problems Low Blood Pressure/ Hypotension (1914); Obstruction/Occlusion (2422); Foreign Body In Patient (2687)
Event Date 05/04/2021
Event Type  Injury  
Event Description
It was reported via medwatch balloon deflation failure occurred.The target lesion was located from the mid left anterior descending artery (lad) all the way back to the left main (lm).Following rotoblating and ballooning, a 3.50 x 48mm synergy xd drug-eluting stent was advanced for treatment and inflated at 12 atm.However, after deflation, the balloon would not come out.The balloon was re-inflated to 20 atm but still would not move.The balloon was reinflated a third time and appeared to rupture as the inflation device would not hold pressure, but the balloon did not deflate.The patient was getting hypotensive so the physician pulled harder and the balloon shaft broke leaving behind an inflated balloon which was occluding flow in the lm and lad.The physician then took a non-boston scientific (bsc) guidewire to try to perforate the balloon but failed.They attempted to remove the device with snares but this was also unsuccessful.A non-bsc 3.00mm x 31mm balloon catheter was used to crush the first stent and balloon out of the way, restoring flow in the lad.A 3.00x31mm synergy xd stent was then used to re-stent the lesion and pin the retained balloon and stent to the vessel wall.After pinning with stents, the contrast in the lad portion of the retained balloon was forced back into the aortic portion.There is now a contrast filled portion of the stent balloon extending from the lm ostium back into the aorta about 10-15mm, touching but does not interfering with the aortic valve function at this point in time.It was noted that the patient required endotracheal intubation and heavy sedation.No further patient complications were reported, and the patient was discharged after a prolonged admission.It was recommended the patient return for a repeat computed tomographic angiography (cta) and echo in three months.
 
Event Description
It was reported via medwatch balloon deflation failure occurred.The target lesion was located from the mid left anterior descending artery (lad) all the way back to the left main (lm).Following rotoblating and ballooning, a 3.50 x 48mm synergy xd drug-eluting stent was advanced for treatment and inflated at 12 atm.However, after deflation, the balloon would not come out.The balloon was re-inflated to 20 atm but still would not move.The balloon was reinflated a third time and appeared to rupture as the inflation device would not hold pressure, but the balloon did not deflate.The patient was getting hypotensive so the physician pulled harder and the balloon shaft broke leaving behind an inflated balloon which was occluding flow in the lm and lad.The physician then took a non-boston scientific (bsc) guidewire to try to perforate the balloon but failed.They attempted to remove the device with snares but this was also unsuccessful.A non-bsc 3.00mm x 31mm balloon catheter was used to crush the first stent and balloon out of the way, restoring flow in the lad.A 3.00x31mm synergy xd stent was then used to re-stent the lesion and pin the retained balloon and stent to the vessel wall.After pinning with stents, the contrast in the lad portion of the retained balloon was forced back into the aortic portion.There is now a contrast filled portion of the stent balloon extending from the lm ostium back into the aorta about 10-15mm, touching but does not interfering with the aortic valve function at this point in time.It was noted that the patient required endotracheal intubation and heavy sedation.No further patient complications were reported, and the patient was discharged after a prolonged admission.It was recommended the patient return for a repeat computed tomographic angiography (cta) and echo in three months.
 
Manufacturer Narrative
The synergy xd mr us 3.50 x 48mm stent delivery system (sds) was returned for analysis without the distal shaft, balloon or stent.A visual and tactile examination found multiple kinks along the hypotube.A visual and tactile examination of the outer lumen and mid-shaft section found a shaft break in the midshaft region of the shaft polymer extrusion measured at approximately 118cm distal to the distal end of the strain relief with the core wire exposed.No other issues were identified during the product analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11881535
MDR Text Key253213668
Report Number2134265-2021-06708
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729985235
UDI-Public08714729985235
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/09/2022
Device Model NumberH7493941848350
Device Lot Number0026373118
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/27/2021
Initial Date Manufacturer Received 05/05/2021
Initial Date FDA Received05/25/2021
Supplement Dates Manufacturer Received08/18/2021
Supplement Dates FDA Received09/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age68 YR
-
-